John Radford - Research output - Research Explorer The University of Manchester

1 results

Filter

2018
Brentuximab Vedotin plus Chemotherapy in High Risk Advanced-Stage Hodgkin Lymphoma (HL) Patients: Results of Pre-Specified Sub-group Analyses from the ECHELON-1 Study
Radford, J., 14 Feb 2018, (Unpublished).
Research output: Contribution to conference › Abstract